UCSF Publishes Gut Microbiome Research Data
HealthWorld from the Economic Times reports that "An international research consortium led by UC San Francisco scientists has shown significant differences between the gut bacteria profiles of multiple sclerosis patients and healthy individuals, as well as between MS patients receiving different drug treatments."
"The study, which was published in Cell on September 15, 2022, describes differences between the gut microbiome profiles of 576 patients and an equal number of household controls in the United States, the United Kingdom, Spain, and Argentina." The consortium plans to expand the study group to additional countries and continue recruiting until that number reaches 2,000. The data will be made public.